节点文献
基于MRI评估三阴性乳腺癌新辅助治疗疗效研究进展
Progress in MRI based evaluation of neoadjuvant therapy for triple-negative breast cancer
【摘要】 三阴性乳腺癌具有侵袭性强、进展快、预后差等不良特点,且对内分泌治疗或分子靶向治疗不敏感。目前,新辅助治疗已成为三阴性乳腺癌的规范疗法,也是最常用的综合治疗方法。近年来,磁共振成像(magnetic resonance imaging,MRI)在评估新辅助治疗疗效方面具有一定的价值,是目前研究的热点。本文对MRI评估三阴性乳腺癌新辅助治疗疗效研究进展作详细地阐述。
【Abstract】 Triple-negative breast cancer is characterized by strong aggressiveness, rapid progression and poor prognosis, and is not sensitive to endocrine therapy or molecular targeted therapy.At present, neoadjuvant therapy has become the standard treatment for TNBC, and it is also the most commonly used comprehensive treatment method.In recent years, MRI has a certain value in evaluating the efficacy of neoadjuvant therapy and is a hotspot of current research.This paper reviews the progress of MRI in the evaluation of neoadjuvant therapy for triple negative breast cancer.
- 【文献出处】 影像研究与医学应用 ,Journal of Imaging Research and Medical Applications , 编辑部邮箱 ,2022年14期
- 【分类号】R737.9;R445.2
- 【下载频次】101